McCormick’s $65.8bn Unilever Foods deal faces UK competition review

McCormick & Company, Incorporated (NYSE: MKC) and Unilever PLC (LSE: ULVR, NYSE: UL) face a new regulatory hurdle after the UK Competition and Markets Authority formally launched a Phase 1 investigation into their planned combination on September 16, 2026. The transaction would merge McCormick with most of Unilever’s Foods business in a structure carrying a combined enterprise value of roughly $65.8 billion, including about $44.8 billion attributed to Unilever Foods and approximately $21 billion to McCormick. The combined company would own brands including Knorr, Hellmann’s, McCormick, French’s, Frank’s RedHot and Cholula, creating a much larger global platform across seasonings, condiments, sauces and foodservice. The UK review does not mean the transaction has been challenged or blocked, but it starts a formal competition timetable with a Phase 1 decision due by November 11. The central issue is whether the scale and cost advantages promised by the combination can survive regulatory scrutiny without remedies that weaken the strategic logic of the deal.

Why has the UK Competition and Markets Authority formally opened its McCormick and Unilever Foods review?

The Competition and Markets Authority is examining whether the proposed transaction could result in a substantial lessening of competition within any UK market. The formal investigation follows an earlier information-gathering period that began in July, when interested parties were invited to comment on the potential competitive impact of the combination. The September 16 commencement means the regulator now considers that it has enough information to start the statutory Phase 1 process.

The inquiry should not be interpreted as evidence that the Competition and Markets Authority has concluded the deal is anti-competitive. Phase 1 is the standard process through which the regulator defines relevant markets, examines overlaps and determines whether potential concerns justify clearance, remedies or a deeper Phase 2 investigation. For McCormick and Unilever, the significance is therefore timing and uncertainty rather than an adverse finding.

The UK matters because both companies have substantial branded-food operations and established retailer relationships. Individual product categories may be considerably more concentrated than the combined company’s broad food portfolio initially suggests, so regulators are likely to examine specific areas such as sauces, condiments, seasonings and foodservice products rather than treating the transaction as one undifferentiated global food market.

How is the $65 billion McCormick and Unilever Foods transaction actually structured?

The transaction is not a conventional all-cash acquisition. Unilever plans to separate most of its Foods business and combine it with McCormick through a Reverse Morris Trust structure designed to create a separately focused flavour and foods company while providing favourable US tax treatment if the required conditions are met. Unilever’s Foods operations in India and certain other excluded businesses will remain outside the transaction.

Unilever and its shareholders are expected to receive 65% of the fully diluted combined company. Existing McCormick shareholders would retain approximately 35%, while Unilever itself is expected to hold approximately 9.9% and Unilever shareholders would own roughly 55.1%. Unilever is also due to receive $15.7 billion in cash, subject to closing adjustments.

The transaction values Unilever Foods at approximately $44.8 billion and McCormick at around $21 billion using the valuation framework announced when the deal was signed. Both sides were valued at approximately 13.8 times 2025 EBITDA under that calculation. The structure therefore resembles a large-scale merger economically, even though McCormick will remain the listed corporate platform and its leadership will run the combined business.

Why are brands such as Knorr, Hellmann’s, French’s and Frank’s RedHot central to the regulatory analysis?

The strategic logic rests heavily on the complementary nature of the brand portfolios. Unilever Foods brings Knorr and Hellmann’s alongside regional cooking aids, sauces and foodservice products, while McCormick owns brands including McCormick, French’s, Frank’s RedHot, Cholula, OLD BAY and Lawry’s. Together, the businesses would have generated approximately $20 billion of fiscal 2025 revenue.

Complementarity can support regulatory clearance when two companies operate in neighbouring rather than directly overlapping categories. However, competition authorities generally assess markets at a narrower level, meaning even a diversified global portfolio can generate concerns where the parties are important suppliers of similar products to the same retailers or foodservice customers.

Retailer bargaining power will also matter. Large supermarket groups can negotiate aggressively with major suppliers, but combining several prominent brands under one owner can increase the supplier’s leverage across category negotiations. The Competition and Markets Authority may therefore examine not only consumer choice but also whether the enlarged company could influence pricing, promotions or shelf competition in specific categories.

How important are McCormick’s projected $600 million of annual synergies to the deal economics?

McCormick expects the transaction to generate approximately $600 million of annual run-rate cost synergies after reinvestment, with around two-thirds expected by the end of the second year and the full amount targeted by year three. The savings are expected to come from procurement, manufacturing and selling, general and administrative expenses. McCormick also expects another $100 million of cost and revenue opportunities to be reinvested into growth.

These synergies are important because the transaction requires substantial financing and integration expenditure. McCormick expects around $300 million of one-time costs to capture the planned savings, while the $15.7 billion cash payment to Unilever creates a significantly larger financing requirement than McCormick has historically carried. Achieving synergies on schedule therefore has direct implications for earnings accretion, leverage reduction and investor confidence.

McCormick expects the combination to improve net sales growth, operating margin and adjusted earnings per share during the first full year after closing. Management previously targeted mid to high single-digit adjusted EPS accretion within the first 12 months and mid to high teens accretion by year three. Those targets become harder to achieve if regulatory remedies force divestitures in high-margin product categories or reduce expected procurement and manufacturing efficiencies.

How does the $15.7 billion cash payment change McCormick’s balance-sheet risk?

McCormick arranged commitments for a senior unsecured bridge facility of up to $15.7 billion when the transaction was signed. The bridge financing is intended to ensure closing certainty if permanent financing has not been completed before the transaction closes. Management ultimately expects the combined company’s cash generation to support the debt structure and subsequent deleveraging.

The financing transforms the scale of McCormick’s capital structure. A company historically valued for defensive consumer demand, brand strength and dividends would emerge from the transaction with materially higher financial obligations. That does not make the deal inherently excessive, but it raises the importance of integration execution and stable cash flow across the combined portfolio.

Higher leverage also reduces room for operational disappointment. Weak consumer demand, commodity inflation, slower synergy delivery or regulatory divestitures could delay debt reduction and constrain future capital allocation. The transaction therefore links food-brand consolidation directly to financing discipline in a way that smaller McCormick acquisitions did not.

What does McCormick’s recent share-price performance say about investor confidence in the merger?

McCormick shares closed at $49.86 on September 15, down approximately 3.9% from the September 8 close and about 7.6% below the August 17 level. The stock remained within a 52-week range of $44.82 to $72.41 and was trading roughly 31% below its annual high. The share price has therefore remained under pressure well after the transaction was originally announced.

The weakness cannot be attributed solely to the UK investigation because the stock had already declined before the Competition and Markets Authority formally opened Phase 1. Investors have been weighing a broader combination of slower packaged-food growth, the complexity of the transaction, integration risk and the increase in leverage required to finance the cash consideration.

Unilever shares closed at 4,641.5 pence in London on September 15, compared with 4,621 pence on September 9 and 4,512.5 pence on August 17. Unilever has therefore performed differently over the past month, reflecting the fact that its strategic objective is to release value from Foods and become a more concentrated personal care and beauty group rather than absorb the integration burden itself.

What could the UK regulator require if competition concerns emerge during Phase 1?

If the Competition and Markets Authority identifies concerns, the companies could potentially offer remedies designed to address specific overlaps. These could include divesting brands, manufacturing assets, distribution rights or other operations within markets considered too concentrated. Remedies can preserve a transaction while reducing the areas of competitive concern, but they can also reduce the earnings and synergy pool originally assumed by management.

A more consequential outcome would be referral to a Phase 2 investigation. That would extend the regulatory timetable and subject the transaction to deeper economic analysis. McCormick and Unilever currently expect the broader transaction to close around mid-2027, so a prolonged UK process could become increasingly relevant to integration planning and financing.

The November 11 Phase 1 deadline is therefore the next important UK milestone. Clearance would remove one layer of uncertainty, while remedies or a Phase 2 referral would force investors to reassess both timing and economics. Other regulatory approvals remain separate, meaning UK clearance alone would not complete the transaction.

Why could the deal reshape competition across global sauces, seasonings and foodservice markets?

The combined company would have a broader geographic footprint than either business individually, with Unilever Foods contributing deeper exposure across Europe, Latin America and Asia while McCormick brings substantial strength in North America. That creates cross-selling opportunities because brands with strong positions in one region can potentially use the other company’s distribution infrastructure to expand elsewhere. McCormick has specifically highlighted the opportunity to grow Unilever Foods brands in North America while using Unilever Foods infrastructure to expand McCormick brands internationally.

Foodservice is another important dimension. The combined platform would have approximately $6 billion of 2025 foodservice sales, linking McCormick’s customer relationships with Unilever Foods’ chef-led operations. Greater scale could support innovation and procurement efficiencies, but it could also encourage competitors to accelerate partnerships, acquisitions or brand investment.

The transaction therefore has implications beyond two companies. If regulators permit the combination largely intact and management achieves its planned synergies, other packaged-food groups may become more willing to pursue large category-focused combinations. If regulatory remedies or integration difficulties materially reduce the returns, the deal could reinforce the argument for smaller portfolio transactions instead.

What evidence will determine whether the McCormick and Unilever Foods combination remains attractive?

The immediate test is regulatory progress, beginning with the Competition and Markets Authority’s November 11 deadline. A clean Phase 1 clearance would improve deal visibility, while substantial remedies or a deeper investigation would place more pressure on the original timetable. Investors will also need to monitor approvals in other jurisdictions before treating completion as assured.

The second test is financing. McCormick must convert committed bridge financing into a durable capital structure capable of supporting the $15.7 billion cash payment without undermining investment or shareholder distributions. The cost and maturity profile of permanent financing will therefore influence the true acquisition economics.

The third test arrives after closing, when management must turn $600 million of projected cost synergies and wider revenue opportunities into measurable earnings and cash flow. The strategic rationale strengthens if the enlarged company grows faster while reducing leverage on schedule. It weakens if regulatory concessions shrink the portfolio, financing costs remain elevated or integration complexity delays the operating improvements needed to justify the transaction.

Key takeaways on what the UK review means for the McCormick and Unilever Foods transaction

• The UK Competition and Markets Authority formally launched its Phase 1 investigation on September 16, with a decision deadline of November 11.
• The review is a regulatory process rather than a finding that the transaction harms competition.
• Unilever Foods is valued at approximately $44.8 billion, while McCormick was valued at about $21 billion within the announced transaction framework.
• Unilever and its shareholders are expected to own 65% of the combined company, leaving current McCormick shareholders with approximately 35%.
• Unilever is also due to receive $15.7 billion in cash, creating a substantial financing requirement for McCormick.
• McCormick expects approximately $600 million of annual run-rate cost synergies by year three, making regulatory remedies important to the deal economics.
• The combined portfolio would include Knorr, Hellmann’s, McCormick, French’s, Frank’s RedHot and Cholula across retail and foodservice markets.
• McCormick shares closed at $49.86 on September 15, roughly 31% below their 52-week high, reflecting broader investor caution around growth, leverage and execution.
• A Phase 2 referral or substantial divestiture requirements could delay closing and reduce expected synergies.
• The next measurable proof point is the November 11 UK decision, followed by financing progress and regulatory approvals in other jurisdictions.